Automated Microbiology Market worth $24.74 billion by 2030, growing at a CAGR of 11.87% - Exclusive Report by 360iResearch

The "Automated Microbiology Market by Component (Hardware, Services, Software), End-User (Agriculture, Education & Academic Institutions, Environmental Monitoring) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Automated Microbiology Market to grow from USD 11.27 billion in 2023 to USD 24.74 billion by 2030, at a CAGR of 11.87%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/automated-microbiology?utm_source=openpr&utm_medium=referral&utm_campaign=sample

Automated microbiology is a sector within microbiology that employs technology-driven processes and equipment to enhance the speed, accuracy, and efficiency of microbial analyses. This includes the use of automated systems for the detection, enumeration, and identification of microorganisms in various samples. Through advanced software, robotics, and sophisticated culture methods, automated microbiology minimizes human error, reduces manual labor, and accelerates diagnostic and research outcomes. The expansion of automated microbiology is primarily propelled by the increasing demand for rapid microbiological testing methods in industries such as healthcare, food and beverage, and pharmaceuticals. The escalating need for more efficient diagnostics, coupled with advancements in molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), significantly drive the market's growth. Additionally, the rising prevalence of infectious diseases and the growing importance placed on food safety standards further contribute to the sector's expansion. High capital investments required for the installation of advanced automated systems hamper the growth of the market. Additionally, the complexity of microbial testing and the need for highly skilled personnel to operate sophisticated automated systems further limit market expansion. The integration of artificial intelligence and machine learning into microbiological testing processes offers new opportunities for innovation and improvement, enhancing the market's potential for growth.

The Americas represent a significant market for automated microbiology due to advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of leading market players. The United States is a dominant force in this region, driven by a high adoption rate of automated solutions in diagnostic laboratories and ongoing investments in healthcare technology research and development. South America is also witnessing growth fueled by improving healthcare facilities, rising awareness of infectious diseases, and the gradual adoption of automated systems in countries like Brazil and Mexico. The APAC region is emerging as a rapidly growing market for automated microbiology, attributed to its vast population, increasing healthcare spending, and growing prevalence of infectious diseases. Countries such as China and India are at the forefront, leveraging their expanding healthcare infrastructure and increased investments in healthcare technology. Additionally, the region's focus on research and development activities, coupled with government initiatives to modernize healthcare services, is propelling the adoption of automated microbiology solutions. Europe holds a significant position in the global automated microbiology market, driven by well-established healthcare systems, strong regulatory frameworks, and high awareness levels regarding advanced diagnostic methods. Germany, the United Kingdom, and France are key contributors, with a high demand for automated systems in clinical diagnostics. The Middle East and Africa (MEA) region is experiencing growth due to increasing healthcare investments, especially in the Gulf Cooperation Council (GCC) countries, focusing on healthcare infrastructure improvements and advancements in technology.

Market Segmentation & Coverage:

This research report categorizes the Automated Microbiology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Hardware, Services, and Software. The Hardware is further studied across Automated Incubators, Bacterial Colony Pickers, Imaging Systems, Plate Reader, and Specimen Processors. The Hardware is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Agriculture, Education & Academic Institutions, Environmental Monitoring, Food & Beverage, Hospital & Clinical Laboratories, and Pharmaceutical & Biotechnology Firms. The Environmental Monitoring is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 40.98% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/automated-microbiology?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Automated Microbiology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Automated Microbiology Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Automated Microbiology Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company (BD), BIOMÉRIEUX, bioMérieux Industry, bioMérieux SA, Bruker Corporation, Cepheid Inc., Copan Diagnostics Inc., Danaher Corporation, Hardy Diagnostics, Labcompare, Luminex Corporation, Merck KGaA, Neogen Corporation, PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., Siemens Healthineers AG, Sysmex Corporation, T2 Biosystems, Inc., Thermo Fisher Scientific Inc., and Whitelake Software Point Oy.

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Automated Microbiology Market, by Component
7. Automated Microbiology Market, by End-User
8. Americas Automated Microbiology Market
9. Asia-Pacific Automated Microbiology Market
10. Europe, Middle East & Africa Automated Microbiology Market
11. Competitive Landscape
12. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Automated Microbiology Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Automated Microbiology Market?
3. What is the competitive strategic window for opportunities in the Automated Microbiology Market?
4. What are the technology trends and regulatory frameworks in the Automated Microbiology Market?
5. What is the market share of the leading vendors in the Automated Microbiology Market?
6. What modes and strategic moves are considered suitable for entering the Automated Microbiology Market?

Read More @ https://www.360iresearch.com/library/intelligence/automated-microbiology?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.